GCIA
ISLEW

Gabelli & Co Investment Advisers’s Isleworth Healthcare Acquisition Corporation Warrant ISLEW Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ISLEW Stock Details ISLEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-48,850
Closed -$2K – 512
2022
Q2 		$2K Hold
48,850
– – ﹤0.01% 483
2022
Q1 		$8K Hold
48,850
– – ﹤0.01% 473
2021
Q4 		$24K Hold
48,850
– – ﹤0.01% 436
2021
Q3 		$27K Hold
48,850
– – ﹤0.01% 420
2021
Q2 		$34K Hold
48,850
– – ﹤0.01% 408
2021
Q1 		$23K Buy
+48,850
New +$23.4K ﹤0.01% 404

Gabelli & Co Investment Advisers's ISLEW Position: Q3 2022 in Review

Gabelli & Co Investment Advisers sold out of Isleworth Healthcare Acquisition Corporation Warrant (ISLEW) in Q3 2022, closing a stake of 48,850 shares — an estimated $2K sold.

Gabelli & Co Investment Advisers first reported a position in ISLEW in Q1 2021 and held it in 6 quarters. The position peaked at $34K in Q2 2021. 0 funds tracked by Wall St. Rank hold ISLEW as of Q3 2022.

  • Gabelli & Co Investment Advisers reported no remaining Isleworth Healthcare Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 48,850 Isleworth Healthcare Acquisition Corporation Warrant shares in Q3 2022, an estimated $2K.
  • Gabelli & Co Investment Advisers first reported a position in Isleworth Healthcare Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
  • Gabelli & Co Investment Advisers's Isleworth Healthcare Acquisition Corporation Warrant position peaked at $34K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Warrant as of Q3 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.